Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy

被引:17
作者
Barrón, Y
Cole, SR
Greenblatt, RM
Cohen, MH
Anastos, K
DeHovitz, JA
Delapenha, R
Gange, SJ
机构
[1] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Cook Cty Hosp, Chicago, IL 60612 USA
[4] Montefiore Med Ctr, Lincoln Med & Mental Hlth Ctr, Bronx, NY 10467 USA
[5] SUNY Downstate Med Ctr, Brooklyn, NY USA
[6] Howard Univ, Washington, DC 20059 USA
关键词
antiretroviral therapy; cohort studies; confounding; discontinuation; HIV/AIDS;
D O I
10.1097/01.aids.0000131359.37210.1f
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To estimate the effect of discontinuing antiretroviral therapy (ART) on survival, among women who initiated highly active antiretroviral therapy (HAART). Design: A multicenter cohort study. Methods: A total of 951 HAART-initiated women were followed for total mortality between 1995 and 2002. The relative hazard (RH) of death attributable to discontinuing all ART was estimated using an inverse probability of treatment-weighted marginal structural Cox proportional hazards model, as well as standard Cox models. Results: Three hundred and forty-three out of 951 women discontinued all ART during the 3187 person-years of follow-up, and 116 died. The RH of death attributable to discontinuation was 1.97 [95% confidence interval (Cl) 1.17, 3.31] from the marginal structural Cox model. A RH of 1.49 (95% Cl 0.94, 2.35) was observed using the same set of covariates in a standard Cox model. Conclusion: An increased risk of mortality for those HAART initiators who discontinued ART was observed using a marginal structural Cox model. This increased risk was independent of measured treatment failure, and was greatly attenuated in a standard Cox model with time-varying covariates. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:1579 / 1584
页数:6
相关论文
共 28 条
[1]   The Women's Interagency HIV Study [J].
Barkan, SE ;
Melnick, SL ;
Preston-Martin, S ;
Weber, K ;
Kalish, LA ;
Miotti, P ;
Young, M ;
Greenblatt, R ;
Sacks, H ;
Feldman, J .
EPIDEMIOLOGY, 1998, 9 (02) :117-125
[2]   GUIDELINE FOR FLOW CYTOMETRIC IMMUNOPHENOTYPING - A REPORT FROM THE NATIONAL-INSTITUTE-OF-ALLERGY-AND-INFECTIOUS-DISEASES, DIVISION OF AIDS [J].
CALVELLI, T ;
DENNY, TN ;
PAXTON, H ;
GELMAN, R ;
KAGAN, J .
CYTOMETRY, 1993, 14 (07) :702-715
[3]   Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models [J].
Cole, SR ;
Hernán, MA ;
Robins, JM ;
Anastos, K ;
Chmiel, J ;
Detels, R ;
Ervin, C ;
Feldman, J ;
Greenblatt, R ;
Kingsley, L ;
Lai, SH ;
Young, M ;
Cohen, M ;
Muñoz, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (07) :687-694
[4]   Fallibility in estimating direct effects [J].
Cole, SR ;
Hernán, MA .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (01) :163-165
[5]   RELATION OF POOLED LOGISTIC-REGRESSION TO TIME-DEPENDENT COX REGRESSION-ANALYSIS - THE FRAMINGHAM HEART-STUDY [J].
DAGOSTINO, RB ;
LEE, ML ;
BELANGER, AJ ;
CUPPLES, LA ;
ANDERSON, K ;
KANNEL, WB .
STATISTICS IN MEDICINE, 1990, 9 (12) :1501-1515
[6]   Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis [J].
Detels, R ;
Tarwater, P ;
Phair, JP ;
Margolick, J ;
Riddler, SA ;
Muñoz, A .
AIDS, 2001, 15 (03) :347-355
[7]   Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration [J].
Detels, R ;
Muñoz, A ;
McFarlane, G ;
Kingsley, LA ;
Margolick, JB ;
Giorgi, J ;
Scharager, LD ;
Phair, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17) :1497-1503
[8]  
*DHHS HJ KAIS FAM, 2002, PAN CLIN PRACT TREAT
[9]   Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimens [J].
Dorrucci, M ;
Pezzotti, P ;
Grisorio, B ;
Minardi, C ;
Muro, MS ;
Vullo, V ;
Monforte, AD .
AIDS, 2001, 15 (13) :1733-1736
[10]   Serum albumin is a powerful predictor of survival among HIV-1-infected women [J].
Feldman, JG ;
Gange, SJ ;
Bacchetti, P ;
Cohen, M ;
Young, M ;
Squires, JE ;
Williams, C ;
Goldwasser, P ;
Anastos, T .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (01) :66-73